NorthShore Weight and Metabolism

02/23/2026

https://www.facebook.com/share/p/17mL7s2hqR/

Many patients are getting GLP-1s from websites and medical spas. But there’s much less oversight.

01/07/2026

Still pricey out of pocket, but MUCH more accessible to many people!

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.

11/18/2025

Have a look ladies!!

11/18/2025

🍏 What a moment.
🍏 I'm so grateful that this is FLOODING social media and the regular media to the point that no one can POSSIBLY be unaware of what has been going on for many years, and what now will change.
🍏 Read! Watch! Listen!

When I raise the topic of with my friends or patients, I will occasionally hear "Oh I don't need that.."
Let's work to change that way of thinking, and change what we define as "need". This is not just about hot flashes and mood swings. This is about better long-term health.

👉 Everyone needs that.



🍏 Learn more about evidence-based menopause care:

www.northshoreweightandmetabolism.com

If you have been on social media in the last 24 hours, you have probably seen the flood of posts about the FDA’s decision to remove the black box warning from menopausal hormone therapy.

07/16/2025

There are lots of misconceptions out there. We asked experts about the biggest offenders.

07/16/2025

🍏 Have a look 👇👇

There are lots of misconceptions out there. We asked experts about the biggest offenders.

05/12/2025

Hot Flashes & Cool Friends 🔥🧊
A Menopause Workshop (Yes, We’re Talking About That)

THIS WEDNESDAY!

Feeling like your thermostat’s broken? Mood swinging like a playground? Wondering if your memory took an extended vacation?

Join us for a real-talk workshop where we laugh, learn, and sweat (sometimes literally) through all things menopause. Bring your questions, your sense of humor, and your fan (trust us, you'll want it).

Let’s normalize the midlife magic and navigate the pause like the queens we are. 👑
No shame. No fluff. Just hot truths and cool support.



See more information here...and JOIN US!

Motivate looks for opportunities to learn and socialize outside of our normal studio classes. Our workshops and socials are chances to be exposed to different health and movement topics, partake in fundraisers and community-based offerings as well as just connect with your fellow Motivators off the

05/02/2025

🍏 This is BEYOND exciting.

I have had several patients now, who AFTER starting HRT have noticed subtle improvements in how they feel their GLP-1 medication is working. Incredible!

💙💚 It's definitely a promising concept in helping perimenopausal and postmenopausal women get control of their health and weight.

www.northshoreweightandmetabolism.com

Do GLP-1s work differently in women — and does menopause blunt their effect?
Emerging research suggests the answer is yes. And the missing link may be estrogen.👇

Studies show that women often experience greater weight loss, improved glucose control, and better lipid profiles on GLP-1 receptor agonists (like liraglutide, semaglutide) compared to men. But after menopause, these benefits seem to decline. Why?

🧬 Estrogen appears to enhance GLP-1 efficacy by influencing the same brain regions that regulate appetite, reward, insulin secretion, and metabolic homeostasis.
📉 In animal models, estrogen loss impaired GLP-1 response—and estrogen replacement restored it.
💡 In humans, women have ~32% greater drug exposure and stronger glycemic response than men, independent of weight. But postmenopausal women often lose this edge.

That’s why researchers are now studying GLP-1 + estrogen conjugates—a targeted therapy that delivers estrogen directly to GLP-1 receptor sites (like the brain and pancreas), avoiding systemic side effects.

In preclinical models, this dual approach leads to:
✅ Greater weight and fat loss
✅ Improved glucose tolerance
✅ Reduced liver fat (MASLD/MASH)
✅ Enhanced insulin secretion + beta-cell protection
✅ Appetite regulation without gynecologic side effects

For postmenopausal women with obesity, T2D, or fatty liver, this could be transformative. Because menopause isn’t just a hormonal shift—it’s a metabolic one.

Precision medicine must include sex-specific therapies that reflect hormonal status and timing. Women aren’t smaller men. We deserve better.

05/02/2025

🍏 We’re getting better at treating obesity—not just with medications like GLP-1s, but with what comes after the weight loss too.

🍏 One of the biggest challenges? Keeping the weight off once the medication stops.

💙 A new procedure called Revita® is showing real promise in helping maintain weight loss after GLP-1 medication by targeting insulin resistance at its source—the duodenum. This minimally invasive approach could become a game-changer in metabolic health.
Still in development but TRULY exciting!!!!

💙 Science is catching up to what we’ve known all along: obesity is not just about willpower—it’s about biology.

🍏 visit us 👇👇👇👇so we can help launch your weight loss journey!

www.northshoreweightandmetabolism.com

04/29/2025

🍏 My advice? Follow as many well-reputed and established experts as possible, to get a jump start on your education about your health.

🍏 Then come see a local expert to discuss more and get you on your way to a healthier you!

🍏 Have a look at our new MenopauseRx program- visit 👇👇👇

www.northshoreweightandmetabolism.com